Special Issue "Implementation of Nanomaterials for Drug Delivery"
A special issue of Nanomaterials (ISSN 2079-4991).
Deadline for manuscript submissions: closed (31 December 2020).
Nanomaterials have sparked a new era of therapeutic interventions. By engineering nanomaterials, the obstacles of conventional therapeutic intervention can be surpassed through sustained release, targeted drug therapy, and local delivery to a specific site of action. Local delivery improves the bioavailability of the therapeutic and reduces off-target adverse effects. Nanomaterials, such as those composed of lipids or polymers, can be used to carry drugs. Inorganic nanomaterials, such as those made of metals, can be readily functionalized and act as therapeutic modalities through photothermal and photoacoustic properties as well as radiative enhancement effects. Nanoparticles also offer a means to transport agents to diseased cells or tissues or act as diagnostic tools. Implantable devices with specially designed nanochannels allow for controlled and sustained release of therapeutics from a drug reservoir near a target site, minimizing adverse effects associated with systemic drug exposure. This Special Issue aims to explore the use of nanomedicine and nanomaterials to enhance therapeutic delivery. In harnessing nanotechnology, which consists of small, highly tunable platforms, we can develop effective therapeutics, devices, and techniques to vastly improve drug delivery and improve therapeutic outcomes.
Dr. Carly S. Filgueira
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug delivery
- implantable devices
- targeted therapy
- site-specific drug action
- sustained release